Benefits of SGLT2i for the treatment of heart failure irrespective of diabetes diagnosis: a state-of-the-art review
Publication date:
2022
Publisher version:
Citación:
Diabetes Therapy, 13(Suppl. 1), p. 19-34 (2022); doi:10.1007/s13300-022-01278-0
Descripción física:
p. 19-34
Patrocinado por:
AstraZeneca